CA1259074A - Carbostyril derivative and process for preparing same - Google Patents

Carbostyril derivative and process for preparing same

Info

Publication number
CA1259074A
CA1259074A CA000562864A CA562864A CA1259074A CA 1259074 A CA1259074 A CA 1259074A CA 000562864 A CA000562864 A CA 000562864A CA 562864 A CA562864 A CA 562864A CA 1259074 A CA1259074 A CA 1259074A
Authority
CA
Canada
Prior art keywords
mixture
compound
hydroxy
methylethyl
carbostyril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000562864A
Other languages
French (fr)
Inventor
Akira Tsunashima
Takeo Iwakuma
Katsuo Ikezawa
Osasi Takaiti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838334494A external-priority patent/GB8334494D0/en
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to CA000562864A priority Critical patent/CA1259074A/en
Application granted granted Critical
Publication of CA1259074A publication Critical patent/CA1259074A/en
Expired legal-status Critical Current

Links

Abstract

Abstract:
The present invention is directed to compounds of the formula:

Description

?r~
-Carbostyril derivative and process for preparing same The present application has been divided out of Canadian Patent Application Serial No. 470,917, filed December 21, 1984.
This invention relates to novel intermediates useful in the preparation of carbostyril derivatives and a process for preparing same.
According to the invention there is provided a . componnd of the formula:

c (I) Y H
wherein YO is a protected hydroxy group.

The compounds II) are useful as intermediates in the preparation of carbostyril derivatives of the formula:

CH

H ~ 3 (I) H

~ .

or a pharmaceutically acceptable acid addition salt thereof.
The carbostyril derivatives and pharmaceutically acceptable acid addition salts thereof show potent ~2-adreno-ceptor stimulating action and are useful as bronchodilators.
The compound (I) of the present invention can exist in the form of four optical isomers (i.e., the (R)(R)-, (R)(S)-, (S)(R)- and (S)(S)-isomers) due to the two asymmetric carbon atoms involved in the side chain.

-CH - CH2 - NH - CH - CH2 ~ OCH3 wherein the asterisk denotes an asymmetric carbon atom.
The present invention includes within its scope all four optical isomers and mixtures thereof.
Throughout the specification, the terms "(R)(R)-isomer", "(R)(S)-isomer", "(S)(R)-isomer" and (S)(S)-isomer" mean the configuration of the asymmetric carbon atoms at the position of -CH(OH)- and that of -C~(CH3)-, respectively. Therefore, for example, "(S)~R)-isomer" means that the asymmetric carbon atom at the position of -CH(OH)- has (S)-configuration and the asymmetric carbon atom at the position of -CH(CH3)-has (R)-configuration. Further, throughout the specification, ~ the term "~-isomer" means a stereoisomer which is a mixture of (R)(R)- and (S)(S)-isomers, and the term "~-isomer" means a stereoisomer which is a mixture of (R)(S)- and ~S)(R)-isomers.
Besides, the com~ounds of the present invention have the following two tautomeric structures which are mut-lally convertible from one to another. Both of these isomers are also included within the scope of the present invention.

3L2~

~ H ~ ~ 3 ~0 Y H ~

N ~ OCH3 ~ H

According to the present invention, the compound (I) is prepared by reducing a compound of the formula:

H ~ 3 (II) YO H
CH
~N/~--OCH3 ~o (III) Y H
wherein YO- is a protected hydroxy~ to give a compound of the formula:

1~i3C!7~

~ N ~ ~ OCH3 (I) ~ .' Y H
wherein YO- is the same as defined above.

In the above-mentioned reactions, a wide variety of protecting groups which have been usually employed to protect hydroxy group can be used as the protecting group (Y).
Examples of such protecting group include lower alkanoyl such as formyl, acetyl and pivaloyl; sustituted or unsubsti-tuted phenyl-lower alkyl such as benzyl, p-methoxybenzyl and 3,4-dimethoxybenzyl; substituted or unsubstituted ben2yloxy-carbonyl such as benzyloxycarbonyl and p-methoxybenzyloxy-carbonyl; or substituted or unsubstituted phenylsulfonyl such a~ benzenesulfonyl and p-toluenesulfonyl.
The reduction of the compound (II) or (III) can be accomplished by reacting it with a reducing agent in a solvent. Suitable examples of the reducing agent include sodium borohydride, lithium aluminium hydride, lithium borohydride, sodium monoacetoxyborohydride, diborane or sodium cyanoborohydride. Methanol, ethanol, isopropanol, dimethylformamide, dimethylsulfoxide, tetrahydrofuran, 125~r~7r~, ether, dimethoxyethane, diglyme, dioxane, toluene or a mixture thereof is suitable as the solvent. It is preferred to carry out the reaction at a temperature of -20 to 30C.
To obtain the carbostyril derivatives of the formula:

HO ~ H
~ 'I

H

5 the hydroxy protecting group Y is removed from the compound of formula I.
The removal of the protecting group can be conducted by conventional methods for example, hydrolysis, organic base treatment or reduction. For example, when the protecting group is formyl, acetyl or benzenesulfonyl, said group may be removed by hydrolysis of the compound (I) with an acid or an alkali. Suitable examples of such acid include, for example, formic acid, trifluoroacetic acid, benzenesulfonic acid, p toluenesulfonic acid, hydrochloric acid or hydrobromic acid.
Suitable examples of such alkali include, for example, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide. This reaction may be conducted with or without a solvent. Examples of the solvent include water, methanol, ethanol or dioxane. It is preferred to carry out the reaction 20 at a temperature of -30 to 70C, especially 20 to 50C. When the protecting group is benzyl, p-methoxybenzyl, 3,4-dimethoxy-benzyl, benzyloxycarbonyl or p-methoxybenzyloxycarbonyl, the removal of said protecting group may be conducted by catalytic hydrogenation o~ the compound (I) in hydrogen gas in the presence of a catalyst. This catalytic hydrogenation is preferably carried out at a temperature of 0 to 100C, 5 especially 20 to 40C, under atmospheric or increased pressure.
Preferred examples of the catalyst include palladium-BaCO3, palladium-charcoal and palladium-black. Methanol, ethanol, tetrahydrofuran, water or a mixture thereof is suitable as the reaction solvent. Further, when the protecting group is acetyl 10 or pivaloyl, said group may be removed by the treatment of the compound (I) with an organic base. The treatment of the compound (I) can be carried out by conventional methods, for example, by treating it with an organic base such as methylamine, dimethylamine, ethylamine or diethylamine. This reaction may 15 be conducted with or without a solvent. Examples of the solvent include water, methanol, ethanol, dioxane or a mixture thereof.
It is preferred to carry out the reaction at a temperature of 0 to 100C, especially 20 to 70C.
When a racemic modification of the compound (II) or 20 (III) (YO- = a protected hydroxy) is used as the starting compound in the above-mentioned reaction, the compound (I) in which YO- is a protected hydroxy, i.e., a compound of the formula:

~ - N ~ ~-OCH (I) ~0 Y'O H

37f~

wherein Y'O- is a protected hydroxy, is obtained in the form of a mixture of two stereoisomers (i.e., ~- and~ -isomers) and may be, if required, separated into each of the stereoisomers prior to removal of the protecting group (Y') th~refrom. For example, each one of the a- and ~-isomers of the compound (I') may be obtained by acylating the compound (I') to give a compound of the formula:

~ (V) Y'O H
wherein RCO- is an acyl group and Y'O- is the same as defined above, subjecting said eompound (V) to chromatography to separate it into each of ~- and ~-isomers thereof, and then removing the acyl group therefrom. The aeylating agent whieh is used for aeylation of the eompound (I') ineludes, for example, aeetyl chloride, aeetyl bromide, chloroaeetyl chloride, p-nitrobenzoyl chloride, and the like. The aeylation is preferably carried out in the presence of an acid aceeptor (e.g., sodium hydroxide, potassium hydroxide, sodium earbonate, potassium earbonate, sodium bicarbonate, potassium biearbonate) in a solvent (e.g., ethyl acetate, methylene ehloride, chloroform, benzene, water or a mixture thereof) at a temperature of 0 to 30C. Subsequent ehromato-graphic separation of ~- and B-isomers of the compound (V) can be effeeted on a column of siliea gel, using methanol, ~L2~

chloroform, methylene chloride, ethyl acetate, benzene, n-hexane or a mixture thereof as an eluant. Then, the removal of the acyl group from the thus-separated each stereoisomer (~- or ~-isomer) of the compound (V1 can be 5 accomplished by conventional hydrolysis thereof, ~or example, by treating said isomer with a base (e.g., potassium hydroxide, sodium hydroxide, potassium carbonate, sodium carbonate) or an acid le.g., hydrochloric acid, sulfuric acid, nitric acid) in a solvent te.g., ~ater, aqueous methanol, aqueous lO ethanol) at a temperature of 20 to lOQC.
~ he ~- or ~-isomer of the compound (I') obtained above (i.e., a mixture of (R)(R)- and (S)(S)-isomers thereof or a mixture of (R)(S)- and (S)(R)-isomers thereof) may be, if required, further separated into each of the optical 15 isomers of the compound tI'). For example, each one of (R)(R)- and (S)(S)-isomers of the compound (I') may ~e obtained by acylating the ~-isomer of the compound (I') with an optically active acylating agent to give a compound of the formula:

COR' CH
HO ~ I ~ 3 ~ ~V') y' H

20 wherein R'CO- is an optically active acyl group and Y'O is ~L25~ ~7~
. g _ the same as defined above, subjecting the compound ~V') to chromatography to separate it into each of (R)(R~- and (S)(S)-isomers of the compound (V'), and then removing the acyl group therefrom. The optically active acylating agent which is used for acylation of the compound (I~) includes, for example, an optically active 1-(2-naphthylsulfonyl)-pyrrolidine-2-carbonyl chloride. The acylation of the compound (I') is carried out in the presence of an acid acceptor ~e.g., sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carb3nate, sodium bîcabonate, potassium bicarbonate) in a solvent (e.g., ethyl acetate, methylene chloride, chloroform, benzene, water or a mixture thereof) at a temperature of 0 to 30C. Subsequent chromato-graphic separation of the (R)(R)- and (S~(S)-isomers of the compound tV') and the removal of the acyl group therefrom may be carried out in the same manner as mentioned hereinbefore.
Each one of (R)(S)- and (S)(R)-isomer of the compound (I') may be obtained from the B-isomer of the compound (I~) in the same manner as above.
On the other hand, the compound (I') which is prepared from an optical isomer of the compound (II) or (III) (YO- = a protected hydroxy) is a mixture of two optical isomers thereof which are a pair of diastereoisomers. For example, a mixture of (R)(R)- and (S)(R)-isomers of the compound (I~) is obtained when the (R)-isomer of the compound (II) or (III) (YO- = a protected hydroxy) is used as the starting ~L25~7.~

compound, while a mixture of (R)(S)- and (S)(S)-isomers of ~he compound (I') is obtained when the (S)-isomer of the compound (II) or (III) (YO- = a protected hydroxy) is used as the star~ing compound. However, said mixture may be, if required, separated into each of the two optical isomers of the compound (I') prior to removal o~ the protecting group (Y') therefrom. For example, each one of the (R)(R)- and (S)(R)-isomers of the compound (I') may be obtained by subjecting the compound (I') to fractional recrystallization;
or by acylating the compound (I') to give the compound (V), subjecting the compound (V) to chromatography to separate it into each of (R)(R)- and (S)(R)-isomers of the compound (V), and then removing the acyl group therefrom. The fractional recrystalli~ation is carried out by recrystallizing the compound (I') from a solvent (e.g., methanol, ethanol, isopropanol, water or a mixture thereof). The acylation of the compound (I') the chromatographic separation and the removal of the acyl group may be carried out in the same manner as described hereinbefore. Each one of the (R)(S)-and (S)(S)-isomers of the compound ~I') may be obtained in the same manner as above.
Moreover, since the B-isomer (or ~-isomer) of the compound (V) separated above can be readily converted into the ~-isomer lor B-isomer) of the compound (I') the compound (I') may be, if required, recovered exclusively in the form of either the ~- or B-isomer thereof. For example, the 3L 25~3/`~7L~

conversion of the B-isomer of the compound (V) into the ~-isomer of the compound lI') is carried out by treating said B-isomer with thionyl chloride in a solvent (e.g., methylene chloride, chloroform, benzene, toluene, tetrahydrofuran, dioxane or dimethoxyethane) to give an ~-isomer of a compound of the formula:

RCOOy~N/~ocH3 ~ (VI) Y'O H

wherein RCO- and Y'O- are the same as defined above, and then removing the acyl group therefrom. The conversion of the ~-isomer of the compound (V) into the ~-isomer of the compound (1') may be carried out in the same manner as above.
Furthermore, the optical isomer of the compound (V) separated above can be readily convertecl into an optical isomer of the compound (I') in which the asymmetric carbon atom at the position of -CH(OH)- has the opposite configuration from that of the former optical isomer. For example, the conversion of the (S)(R)-isomer of the compound (V) into the (R)(R)-isomer of the compound (I~) is carried out by treating the compound (V) with thionyl chloride in a solvent (e.g., methylene chloride, chloroform, benzene, toluene, tetrahydro-', ' 5~

furan, dioxane or dimethoxyethane) to give the (R)(R)-isomer of the compound (VI), and then removing the acyl group therefrom. The conversion oP the (R)(R)-, (R)(S)- or (S~(S)-isomer of the compound lV) into the (S)(R)-, (S)(S)-or (R)(S)-isomer of the compound (I') . may be respectively carried out in the same manner as above.
The starting compound (II) and (III) of the present invention is a novel compound and can be prepared, for example, by the steps of halogenating or oxidizing a compound of the formula:

~ (VII) Y' wherein Y'O- is the same as defined above, to give a compound of the formula:

COCH2X COCH(OH)2 (VIII) or ~ ~ (IX) ~ N ~ O ~ N ~ O
Y'O H Y'o H

wherein X is halogen atom and Y'O- is the same as defined above, reacting the compound (VIII) or (IX) with a compound lS of the formula:

. .

.~ .

- 13 - 1 25 ~r~

H2N-CHCH24~oCH3 (X) to give a compound of the formula:

N ~ oc~3 ~ (II') Y' H
or CH
N ~ H3 ~ (III') Y'O H
wherein Y'O- is the same as defined above.

The compound of the formula (VII) to be used in the above-mentioned process may be prepared, for example, by oxidizing O-protected 5-ace~yl-8-hydroxyquinoline with 80 %

m-chloroperbenzoic acid in a solvent (e.g., chloroform, methylene chloride, tetrahydrofuran, acetonitrile), and then heating the resultant O-protected 5-acetyl-8-hydroxyquinoline N-oxide in a solvent (e.g., acetic anhydride). Alternatively, the compound (VII) may be prepared by introducing a protecting group (Y') into 5-acetyl-8-hydroxycarbostyril (c~., Japanese ~ 14 --patent publication (unexamined) No. 141879/1976) in a conven-tional manner.
Halogenation of the compound IVII) is preferably carried out in a so~vent (e.g., chloroform, methylene chloride, tetrahydrofuran, methanol or a mixture thereoE) at 20 to 60C under stirring. Suitable examples of the halogenating agent include N-bromosuccinimide, N-chlorosuccinimide, bromine or chlorine.
On the other hand, oxidation of the compound (VII) is preferably carried out at 20 to 100C in the presence of an oxidizing agent (e.g., selenium dioxide) in a solvent (e.g., dioxane, tetrahydrofuran or an aqueous mixture thereof).
The reaction of the compound (VIII) or (IX) with the compound (X) may be accomplished at 10 to 30C in a solvent (e.g., d~methylsulfoxide, dimethylformamide, chloroform, methanol, ethanol or a mixture thereof) under stirring.
Further, the removal of the protectinq group (Y') from the compound (II') or (III') may be carried out in the same manner as mentioned hereinbefore.
The compound or an acid addition salt thereof prepared from the intermediate of formula (I) shows potent broncho-dilating activity and long-lasting therapeutic effect thereof, can produce selective stimulation of ~2-adrenoceptor and hence is useful for treatment or prophylaxis of various chronic obstructive pulmonary diseases such as bronchial asthma or chronic bronchitis. For example, when estimated by the use of isolated tracheal chains of .

~;253~4 guinea pigs, the bronchodilating activity of 8-hydroxy-5 1-hydroxy-2-~N-(~lR)-2-(p-methoxyphenyl~-1-methylethyl)-amino3ethyl3carbostyril of the present invention is about lO
and 100 times as strong as those of procaterol (chemical name; 8-hydroxy-5-~1-hydroxy-2-(isopropylamino~butyl~carbostyril hydrochloride hemihydrate, J. Med. Chem., 20(8), 1103(1977~) and Isoproterenol (chemical name: 4-~1-hydroxy-2-~(1-methyl-ethyl)amino~ethyl}-1,2-benzenediol hydrochloride), respectively.
Moreover, since the compound is characteri~ed by the high potency ratio of the ~2-adrenoceptor stimulating action to the ~1-adrenoceptor stimu~ating action such as positive chronotropic action (e.g., increase in heart rate), said compound of the invention has particulary high safety for use as a bronchodilator. In addition, the toxicity of the 15 compound is considerably low.
The carbostyril derivative can be used for pharmaceuti-cal use in the form of either the free base or an acid addition salt thereof. Pharmaceutically acceptable acid addition salts of the carbostyril derivative include, for example, salts thereof with an inorganic acid such as hydrochlo-ric acid, hydrobromic acid, phosphoric acid, nitric acid or sulfuric acid, and an organic acid such as acetic acid, propionic acid, glycolic acid, lactic acid, malic acid, fumaric acid, malonic acid, succinic acid, aspartic acid, ascorbic acid, glutamic acid, nicotinic acid or methanesulfonic acid.
Such pharmaceutically acceptable salts may be prepared, for ~2ssa7~

for example, by treating the free base of the compound with a stoichiometrically equimolar amount of an acid.

The compound and a salt thereof can be administered either orally or parenterally. The pharmaceutical preparation of the compound may be either solid preparations such as tablets, pills, powders~ capsules or granules, or liquid preparations such as solutions, suspensions or ~mulsions.
Such preparations may be prepared in a conventional manner, for example, by admixing a compound or a pharmaceutically acceptable salt thereof ~ith a conventional carrier or diluent such as calcium carbonate, calcium phosphate, corn starch, potato starch, lactose, talc, and magnesium stearate.
The daily dose of the compound or a salt thereof may vary depending on the administration route, the age, weight or conditions of patients and the severity of diseases to be treated. In general, however, a preferred dose of said compound or a salt thereof may be 0.01 to 30~g, especially 0.01 to 3 ~g, per kilogram of body weight per day.
Practical and presently-preferred embodiments of the present in~ention and the invention described in Canadian Patent Application Serial No. 470,917 filed December 21, 1984 from which the present application has been divided are illustratively shown in the following Examples.

Experiment 1 (Bronchodilating activity) Isolated tracheal muscle preparations of Male Hartley guinea pigs (body weight: 430 - 645 g) were used to estimate ., ;. .: .

~L 2/5~3'3~L~

the bronchodilating activity of a test compound according to Magnus' method. The preparation was suspended in an organ bath fillPd with 20 ml of Tyrode's solution (37C), and said solution was continuously bubbled with air. Histamine 2HCl 5 was added to the bath (final concentration; 1 x 10 g/ml) and the test compound was added thereto about 15 minutes after the addition of histamine 2HCl. Tension changes in the tracheal smooth muscle were recorded isometrically with a force-displacement transducer. Molar concentration of the test compound which produced 50 % relaxation of the histamine-induced tracheal contraction were estimated from the concentration-response curve, and the potency ratio of the test compound to Isoproterenol was calculated therefrom.
The result are shown in Table 1.

Table 1 Test compounds Potency ratio Comp. No. 1 166 Comp. No. 2 78 Comp. No. 3 52 Procaterol 17 Isoproterenol Note; Comp. No. 1: 8-Hydroxy-5-~(lR)~l-hydroxy-2-~N-((lR)-2-(p-methoxyphenyI)-l-methylethyl)amino]ethyl~-carbostyril hydrochloride :

. . .

- ~S~7~

Comp. No. 2: 8-Hydroxy-5-~l-hydrOxy-2-~N-(2-(p-methoxy-phenyl)-l-methylethyl)amino~ethyl} carbostyril hydrochloride (d~-isomer obtained in Example 3 mentioned hereinafter) Comp. No. 3: 8-Hdroxy-5-{l-hydroxy-2--~N-t2-(p-methoxy-phenyl)-l-methylethyl)amino~ethyl}carbostyril hydrochloride (a mixture of ~- and ~-isomers) Chemical name of procaterol : 8-Hydroxy-S-tl-hydroxy-2-(isopropylamino)butyl~carbostyril hydrochloride hemihydrate Chemical name of Isoproterenol : 4-~l-hydroxy-2-~(l-methylethyl)amino~ethyl}-l,2-benzenediol hydrochloride.

Experiment 2 tMethod ) Inhibitory effect on antigen-induced bronchoconstriction Male Hartley guinea pigs (body weight: 2$0 - 520 g) were passively sensitized by intravenous injection of rabbit antiserum against ovalbumin (0.2 ml/lO0 g of body weight, PCA titer: x 10001. 24 hours later, the animals were anesthetized with ~-chloralose (120 mg/kg. i.v.) and immobilized with gallamine triethiodide (5 mg/kg, i.v.) under artificial respiration. Lung volume changes were measured as overflow of air from the lung by the Konzett-Rossler method (cf.
Arch. Exp. Pathol. Pharmakol., l95, 71 (1940)). The test compound was administered intravenously to the animals one minute before said animals were challenged with ovalbumin lS (30 ~g/kg, i.v). The ED50 ~i.e., the dose of the test compound which is necessary to produce 50 % reduction of antigen-induced bronchoconstriction) was estimated from the dose-response curve.

' ~, , lZ5~^~7~

Acute toxic_ity A test compound was dissolved in S % glucose solution, and the test compound solution t0.2 ml/10 g of body weight) was administered intra~enously to Male ddY strain mice (body weight: 25 - 28 g). The LD50 of the test compound was estimated by the Up and Down method.
(Results) The results are shown in the following Table 2.

Table 2 .. ._ _ :
Inhibitory effect Acute Therapeutic Test compounds* on antigen-induced toxicity index bronchoconstriction ~LD 0) (ED50) (,ug/kg) (mg/kg) (LD50/ED50) . . _ ~
Comp. No. 1 0.09 84.6 9.4 x lo Comp. No. 2 0.18 91.3 5.1 x 10 Procaterol 0.64 - 70.3 1.1 x 105 Note; * : same as shown in the footnote of Table 1.

Example 1 (1) 293 mg of 5-acetyl-8-benzyloxycarbostyril are dissolved in 15 ml of chloroform, and 200 mg of N-bromo-succinimide are added thereto. The mixture is refluxed for
2 hours under stirring. 300 mg of N-bromosuccinimide are 12S3.~,17 - 2û -added to the mixture and 4 hours after the commencement of the reaction, 100 mg of N-bromosuccinimide are further added thereto. Six hours after the reaction is started, the mixture is cooled and is allowed to stand at 20C for 2 5 days. Precipitated crystals are collected by filtration.
Then, the crystals are washed with methanol and ether and then dried. 110 mg of 5-bromoacetyl-8-benzyloxycarbostyril are thereby obtained as colorless crystals. On the other hand, the filtrate is concentrated to dryness, and the 10 residue is treated in the same manner as above, whereby 60 mg o~ 5-bromoacetyl-8-benzyloxycarbostyril are further recovered from the filtrate. Total yield: 170 mg (45.8 ~) M.p. 203 - 205C (decomp.) (recrystallized from methanol-chloroform) Mass (m/e): 373, 371 (M ) IRI> nu~ol (cm~l) 1675 NMR (d6-DMSO) ~: 4.85(s 2H), 5.39(s, 2H), 6.65(d, J-10 Hz, lH), 7.2 - 7.7(m, 6H), 7.86(d, J=9Hz, lE3), 8.51(d, J=10 Hz, lH) (2) 750 mg of S-bromoacetyl-8-benzyloxycarbostyril are dissolved in S ml of dimethylsulfoxide, and 660 mg of N-(2-(p-methoxyphenyl)-1-methylethyl)amine are added thereto.
The mixture is stirred at room temperature for l.S hours, 25 whereby a mixture containing 8-benzyloxy-5-fl-oxo-2- CN (2-(p-methoxyphenyl)-1-methylethyl)aminol ethyl~carbostyril is ~LZS~7~

obtained. 10 ml of methanol and 380 mg of sodium borohydride are added to the mixture, and the mixture is further stirred at room temperature for one hour. The reaction mixture is extracted with chloroform, and the extract i5 washed with water, dried and then evaporated under reduced pressure to remove chloroform. The residue is purified by silica gel chromatography ~solvent; chloroform : methanol = 9 : 1), and then treated with an ethanol-hydrogen ~hloride solution.
The crude product thus o~tained is recrystallized from a mixture of isopropanol and ether. 210 mg of 8-benzyloxy-5-~1-hydroxy-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)amino~-ethyl}carbostyril monohydrochloride are obtained as colorless crystals. (a mixture of ~- and ~-isomers) Yield: 21.2 M.p. 193 - 212C

Mass (m/e): 440 (M _ H2O) IR ~ chloroform ( -1) 1660
(3) 495 mg of 8-~enzyloxy-5-{1-hydroxy-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)amino~ethyl}carbostyrll monohydro-chloride are dissolved in a mixture of 26 ml of tetrahydro-furan 2Q and 4 ml of water, and 2S0 mg of 10 % palladium-charcoal are added thereto. The mixture is stirred at room temperature for 1.5 hours under a hydrogen atmosphere. After the reaction, the mixture is filtered to remove catalyst, and a 10 ~ methanolic hydrogen chloride solution is added to the filtrate. The mixture is concentrated under reduced pressure~

and the residue is recrystallized from a mixture of isopropanol .

1 Z 5 ~ ~7L~

and ether. 350 mg of 8-hydroxy-5~ hydroxy-2-CN-(2-tp-methoxyphenyl-1-methylethyl)amino3ethyl}carbostyril dihydro-chloride are obtained as colorless crystals. ~a mixture of ~- and ~-isomers) Yield: 79.3 %
M.p. 143 - 154C (decomp.) IR ~ max l (cm 1): 1640 Example ?
tl) 8.35 g of selenium dioxide are dissolved in 10 ml of water, and 250 ml of dioxane and 14.65 g of S-acetyl-8-benzyloxycarbostyril are added thereto. ~he mixture is refluxed for 24 hours under stirring. After the reaction, 300 ml of dioxane is added to the mixture, and the mixture is filtered to remove inorganic materials. Inorganic materials are washed with 200 ml of methanol and 200 ml of 15 dioxane. The filtrate and washings are combined and concent-rated to a~out 200 ml under reduced pressure. 600 ml oP
water and 20 ml of 10 % hydrochloric acid are added to the solution, and the solution is allowed to stand at 20C for 3 hours. Precipitated crystals are collected by filtration, 20 washed with isopropanol-ether and n-hexane and then dried.
14.97 g of 8-benzyloxy-5-(dihydroxyacetyl)carbostyril 1/3 hydrate are obtained. Yield: 88.5 ~ The product is recrystallized from a mixture of dioxane and water to give pale yellow needles.
M.p. 132 - 147C
IR ~ maU~ol (cm 1): 1655, 1682 :; .;.. ,.. ;, .. .. :
' .

~2~f~7~

(2) 993 mg of 8-benzyloxy-5-(dihydroxyacetyl)-carbostyril 1/3 hydrate are dissolved in 10 ml of dimethyl-sulfoxide, and 500 mg of N-(2-(p-methoxyphenyl)-1-methylethyl)-amine are added thereto. The mixture is stirred at room temperature for 2 hours, whereby a reaction mixture containing 8-benzyloxy-5-~1-oxo-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)-imino~ethyl~carbostyril is obtained. The reaction mixture is ice-cooled, and 10 ml o~ methanol and 460 mg of sodium borohydride are added thereto. The mixture is stirred at room temperature for 2 hours. m e reaction mixture is extracted with chloroform, and the extract is washed with water and 10 ~ hydrochloric acid, dried and then evaporated under reduced pressure. The residue is recrystallized from a mixture of isopropanol and etherO 1010 mg of 8-benzyloxy-5-{1-hydroxy-2{N-(2-(p-methoxyphenyl)-1-methylethyl)amino3-ethyl~carbostyril monohydrochloride are obtained as colorless crystals (a mixture of~ - and ~-isomers). Yield: 68 %
M.p. 193 - 212C
Mass(m/e): 440 (M -H20) IR ~ chlorOform ( -l) 1660 (3) 8-Benzyloxy-S-~1-hydroxy-2-~N-(2-(p-methoxy-phenyl)-1-methylethyl~amino~ethyl3carbostyril monohydrochloride is treated in the same manner as described in Example 1-(3), whereby 8-hydroxy-5-~1-hydroxy-2- [N- ( 2- (p-methoxyphenyl)-1-25 methylethyl)amino]ethyl~carbostyril dihydrochloride is obtained. (a mixture of a- and ~-isomers) 1 2~ Lit Example 3 (l) 2.65 g o~ 8-benzyloxy-5-(dihydroxyacetyl)-carbostyril 1/3 hydrate, 1.65 g of N-(2-(p-methoxyphenyl)-1-methylethyl)amine, 30 ml of dimethylsufoKide, 760 mg of 5 sodium borohydride and 20 ml of methanol are treated in the same manner as described in Example 2-(2l. Then, the reaction mixture is extracted with ethyl acetate. The extract is ice-cooled under stirring, and 300 ml o~ an aqueous 3 % sodium hydroxide solution are added thereto. A
lO solution of 2.51 g of acetyl chloride in 10 ml of ethyl acetate is added dxopwise to the mixture at S - 10C. The mixture is stirred at room temperature overnight. The ethyl acetate layer is washed with a saturated sodium bicarbonate solution and a saturated sodium chloride solution successively, 15 dried and then evaporated under reduced pressure to remove ethyl acetate. The residue is chromatographed on the column of silica gel (solvent, chloroform : methanol = 30 :
1), whereby the ~- and B-isomers o~ 8-benzyloxy-5-~1-hydroxy-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)-N-acetylamino~ethyl}-20 carbostyril are obtained, respectively.

U-isomer (i.e., a mixture of 8-benzylcxy-5-~(lR)-1-hydroxy-2-[N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)-N-acetylamino3ethyl~carbostyril and 8-benzyloxy-S-~(lS)-l-hydroxy-2-~N-(lS)-2-(p-methoxyphenyl)-1-methylethyl)-N-acetylaminolethylscarbostyril) ... .

~2~ 7~

Yield: 640 mg (16 %), colorless needles M.p. 177 - 180C (recrystallized from ethyl acetate) Mass (m/e): 482 (M -H2O) ~ nu~ol (cm~l) 1640, 3260~ 3342 NMR (CDCl3) ~ : 1.28 ~d, J= 6.5 Hz, 3H), 1.82 (s, 3H), 2066 td, J= 6.5 Hz, 2H), 3.77(s, 3H), 5.19 (s, 2H), 6.6 - 7.4 (m, 7H), 7.4 (s, SH), 8.35 (d, J= 10.5 H~, lH) lO ~-isomer (i.e., a mixture of 8-benzyloxy-5-~(lR)-l~hydroxy-2-~N-((lS)-2-(p-methoxyphenyl)-1-methylethyl)-N-acetylamino~ethyl~carbostyril and 8-benzyloxy-5-~(lS)-1-hydroxy-2-~N-((lR)-2 (p-methoxyphenyl)-1-methylethyl)-N-acetylamino3ethyl}carbostyril) Yield: 1.805 g (45.1 %), colorless prisms M.p. 162 - 163C (recrystallized from ethyl acetate) Mass (m/e): 482 (M _H2O) ~ nu~ol (cm~l) 1665, 3160~ 3490 NMR (CDCl3) u~: 1.18 (d, J= 6.5 Hz, 3H), 1.91 (s, 3H), 2.5 - 2.8 (m, 2H), 3.76(s, 3H), 5.17 (s, 2H), 6.5 - 7.35 (m, 7H), 7.39 (s, 5H), 8.42 (d, J=10.5 Hz, lH) (2 - a) 500 mg of 8-benzyloxy-5-~1-hydroxy-2-~N-(2-p-methoxyphenyl-1-methylethyl)-N-acetyl aminoi ethyl} carbostyril 5~ ~,7~

(d-isomer) are added to a mixture of 15 ml of methanol and 6 g of an aqueous 5 ~ sodium hydroxide solution. The mixture is refluxed ~or 5 hours under stirring. After the reaction, the mixture is evapora~ed under reduced pressure to remove methanol. The residue is acidified with 10 ~ hydrochloric acid and extracted with chloroform. The ex~ract is washed with water, dried and then evaporated under reduced pressure to remove chloroform. The residue is xecrystallized from a mixture of isopropanol and ether. 47Q mg of 8-benzyloxy-S-{1-hydroxy-2-[N-(2-(p-methoxyphenyl)-1-methylethyl)amino~ ethyl}-carbostyril monohydrochloride ~-isomer) are obtained as colorless needles. Yield: 95 %
M.p. 200 - 203C
Mass (m/e): 440 (M -~2) IR ~ ~ol (cm ): 1652, 2350 - 2750, 3280, 3405 (2 - b) 750 mg of 8-benzyloxy-S-~1-hydroxy-2-LN-(2-(p-methoxyphenyl)-1-methylethyl)-N-acetylamino~ethyl~-carbostyril (~-isomer) are treated in the same manner as described in paragraph (2-a). 680 mg of 8~benzyloxy-5-{1-hydroxy-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)amino3ethyl~-carbostyril monohydrochloride (B-isomer) are obtained as colorless needles. Yield: 91.6 ~
M.p. 217 - 219C (recrystallized from isopropanol-ether) Mass (m/e): 440 (M -H2O) IR ~ max (cm~1): 3290, 3400 1 ;25~r~7~

(3 - a) 247 mg of 8-benzyloxy-5-{l-hydroxy-2-[N-(2 (p-methoxyphenyl)-l-methylethyl3amino~ethyl3carbostyril monohydrochloride (~-isomer) are dissolved in a mixture of 5 ml of tetrahydrofura~ and 1.5 ml of water, and 100 mg of 10 ~ palladium-charcoal are added thereto. The mixture is stirred at room temperature under a hydrogen atmosphere for 1 hourO After the reactionf the mixture is filtered to remove catalyst, and 2 ml of a 10 % methanolic hydrogen chloride solution is added to the filtrate. The mixture is condensed under reduced pressure, and the residue is recrysta-llized from a mixture of isopropanol and ether. 183 mg of 8-hydroxy-S~ hydroxy-2- ~N-(2- (p-methoxyphenyl)-1-methylethyl)-amino~ethyl}carbostyril dihydrochloride-l/3 hydrate (~-isomer) are obtained as colorless crystals. Yield: 82 M.p. 154 - 155C (decomp.) IR ~ nu]ol (C -11 1638 3140 3330 NMR (D2O) ~ : 1.36 (d, J= 7 Hz, 3H), 2.92 (d, J= 8 Hz, 2H), 3.32 (d, J- 6 Hz, 2H), 3.77 (s, 3HI, 5.45 (5, J= 6 HZ, lH), 6.62 (d, J= 10 Hz, lH), 6.80 (d, J= 8 Hz, 2H), 6.95 (d, J= 8HZ, lH), 7.10 (d, J= 8 Hz~ 2H), 7. 20 (d, J= 8 Hz, lH), 8.08 (d, J= 10 Hz, lH) -; :

' ~l 2531rl7 Monohydrochloride:
colorless prisms M.p. 213 - 216C ~decomp.) (recrystallized from methanol-water) (3 - b) 247 mg of 8-benzyloxy-5-~1-hydroxy-2-LN-(2-(p-methoxyphenyl)-1-methylethyl)amino~ethyl}carbostyril monohydrochloride (B-isomer) are treated in the same manner as described in paragraph (3 - a). 175 mg o~ 8-hydroxy-5-fl-hydroxy-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)amino~ethyl3-carbostyril dihydrochloride (B-isomer) are obtained as colorless crystals. Yield: 79.5 ~
M.p. 161 - 163C (decomp.) (recrystallized from isopropanol-ether) ~ nu~ol (cm~l) 1640, 3160, 3375 NMR(D2O) : 1.38 (d, J= 6Hz, 3H), 2.8 - 3.8 ~m, 5H), 3.7.7 (s, 3H), 5.40 (q, J 8 Hz, S Hz, lH), 6.62 (d, J= 9 Hz, lH), 6.81 (d, J= 8 Hz, 2H), 6.96 (d, J= 8 Hz, lH), 7.11 (d, J= 8 Hz, 2H), 7.19 (d, J = 8 Hz, lH), 8.07 (d, J= 9 Hz, lH ) Example 4 (1) 4.60 g of 8-benzyloxy-5-~1-hydroxy-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)amino~ethyl~carbostyril (~-isomer~
are dissolved in 300 ml of chloroform, and 300 ml of an 25 aqueous S ~ potassium carbonate solution are added thereto.

~Z~i3 3.6 g of (S)-1-(2-naphthylsulfonyl)pyrrolidine-2-carbonyl chloride are added dropwise to the mixture with stirring under ice-cooling, ana the mixture is stirred at room temperature for 2 hours. The chloroform layer is collected, dried and then concentrated under reduced pressure to remove solvent. The residue is chromatographed on the column of silica gel (solvent, chlorofrm : methanol - 49 : 1), whereby the following two compounds are obtained, respectively.
8-benzyloxy-5-l(lR)-1-hydroxy-2-~N-((lR)-2-(p-methoxy-phenyl)-1-methylethyl)-N-((2S)-1-(2-naphthylsulfonyl)pyrrolidine-2-carbonyl)amino]ethyl}carbostyril Yield: 2~1 g (28.2 %), colorless caramel IR ~ nu~ol (cm ) 3390, 1650, 1605 Mass (m/e): 727 (M ~ H2O) 8-benæyloxy-5-~(lS)-1-hydroxy-2-tN-((lS)-2-(p-methoxy-phenyl)-1-methylethyl)-N-((2S)-1-(2-naphthylsulfonyl)pyrrolidine-2-carbonyl)amino~ethyl}carbostyril Yield: 2.2 of (29.5 %), colorless caramel IR ~ max l (cm 1): 3390, 1650, 1605 Mass (m/e): 727 (M ~ H2O) (2-a) 2.61 g of 8-benzyloxy-5-~lR)-1-hydroxy-2-tN-((lR)--2-(p-methoxyphenyl)-1-methylethyl)-N-((2S) 1-f2-naphthylsulfonyl)-pyrrolidine-2-carbonyl)amino~ethyl}carbostyril are dissol~ed in 100 ml of methanol, and 35 ml of lN potassium hydoxide-methanol and 10 ml of water are added thereto. The mixture is refluxed for 3 hours with stirring. The mixture is concentrated 3 -- ~ 9!f~7~

under reduced pressure to remove solvent. The residue is extracted with chloroform, and the extract is washed with 5 ~ hydrochloric acid, dried and then concentrated under reduced pressure to remove solvent. The residue is recrystallized 5 ~rom a mixture of isopropanol and water. 1.1 g of 8-benzyloxy-S-{(1~)-1-hydroxy-2- ~N- ( ~ lR ) -2-(p-methoxyphenyl)-1-methylethyl)-amino3ethyl}carbostyril hydrochloride are obtained as colorless ; prisms. Yield: 63.6 ~
M.p. 203 - 205C (decomp.) lO Free base:
M.p. 130.5 - 132.5C
r~ D -45.31 (c = 1.05, methanol) IR ~ mU~ol (cm 1): 3340, 3160, 1640 Mass (mte): 440 (M ~ H2O) NMR (CDC13) C~ : 1.08 (d, J = 6.7 Hz, 3H), 2.5 - 3.0 (m, SH), 3.76 (s, 3H,), 4.~ - S.10 (m, lH), 5.14 (s, 2H), 6.5 - 7.3 (m, 7H), 7.39 (s, SH), 8.0S (d, J = 9.6 Hz, lH) (2-b) 2.61 g of 8-benzyloxy-S-~(lS)-1-hydroxy-2-~N-20 ((lS)-2-(p-methoyphenyl)-1-methylethyl)-N-((2S)-1-(2-naphthyl-sulfonyl)-pyrrolidine-2-carbonyl)amino]ethyl}carbostyril are dissolved in 100 ml of methanol, and 35 ml of lN potassium hydroxide-methanol and 10 ml of water are added thereto.
The mixture is refluxed for 3 hours with stirring. The 25 mixture is concentrated under reduced pressure to remove solvent. The residue is extracted with chloroform, and the 1 ~,59,r~7~¦

extract is dried and concentrated under reduced pressure to remove solvent. The residue is recrystallized twice from ethyl acetate. 1.1 g of 8-benzyloxy-5-~(lS)-1-hydroxy-2-~N-((lS)-2-(p-methoxyphenyl)-1-methylethyl)amino~ethyl~-carbostyril are obtained as colorless needles. Yield: 68.8 %
M.p. 130.5 - 132C

~d~D ~ 40 9 (c = 1.0, chloroform) ~ nu~ol (cm~l) 3340, 3160, 1640 Mass (m/e): 458 (M ), 440 (M - H2O) NMR (CDCl3) ~ : 1.08 (d, J = 6.7 Hz, 3H), 2.5 -3.0 (m, 5H~, 3.76 (s, 3H), 4.8 -5.10 (m, lH), 5.14 (s, 2H) 6.5 -7.3 (m, 7~), 7.39 (s, 5H), 8.05 (d, J = 9.6 Hz, lH) (3-a) A mixture of 3.5 g of 8-benzyloxy-5-{(lR)-1-hydroxy-2-[N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)amino]-ethyl}carbostyril hydrochloride, 240 mg of 10 % palladium-charcoal, 100 ml of tetrahydrofuran and 10 ml of water is shaken at room temperature at an atmospheric pressure under 20 a hydrogen atmosphere for 2 hours. Insoluble materials are collected by filtration and washed with an aqueous 10 %
ethanol solution. The filtrate and washings are combined, and the combined solution is concentrated under reduced pressure to remove solvent. The residue is crystallized 25 with a mixture of ethanol, water and isopropyl ether, and crystalline precipitates are collected by filtration. 2.38 32 - ~3 37~

g of 8-hydroxy-5-~(lR)-1-hydroxy-2-[N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)amino]ethyl~carbostyril hydrochloride are obtained as colorless crystals. Yield: 83 %
M.p. 170.0 - 171.5C (decomp.) ~D -64.40 (c = 1.00, methanol) IR ~ maU~ 1 (cm 1)~ 3300 (broad), 1640, 1610, 1600 NNR ~D2O) ~ : 1.3S (d, J a 7Hz, 3H), 2.92 (d, J = 8Hz, 2H), 3.32 (d, J = 6H2, 2N), 3.77 (s, 3H), 5.45 ~t, J = 6Hz, lH), 6.62 (d, J = lOHz, lH), 6.80 ~d, J =
8Hz, 2H), 6.95 (d, J = 8Hz, 1~), 7.10 (d, J = 8~z, 2H), 7.20 (d, 8Hz, 1~), 8.08 (d, J = lO~z, 1~) (3-b) A mixture of 916 mg of 8~benzyloxy-5-f(lS)-1-hydroxy-2-[N~ s)-2-(p-methoxyphenyl)-l-methylethyl)amino]
ethyl3carbostyri.1, 100 mg of 10 ~ palladium-charcoal, 2 ml of lN hydrochloric acid and 20 ml of tetrahydrofuran is shaken at room temperature at an atmospheric pressure under a hydrogen atmosphere for 2 hours. Insoluble materials are collected by filtration and washed with an aqueous 10 ~
ethanol solution. The filtrate and washings are combined, and the combined solution is concentrated under reduced pressure to remove solvent. The residue is crystallized with a mixture of methanol and ether, and crystalline 25 precipitates are collected by filtration. 623 mg o~ 8-hydroxy-5-~(lS)~1-hydroxy-2-~N-((lSj-2-(p-methoxyphenyl)-1 , . . ..

~L25~ 7 methylethyl)amino)ethyl~carbostyril hydrochloride are obtained as colorless crystals. Yield: 77 %
M.p~ 166 - 167C (decomp.) ~ D + 65.5 tc = 1.0, methanol) I~ ~ u~ l (cm l): 3390, 3320, 1640, 1610, 1600 The Mass and NMR data of this product are identical with those of the product obtained in the above-mentioned paragraph (3-a).
Example 5 (1) 330 mg of 8-benzyloxy-5-(dihyroxyacetyl1carbostyril 1/3 hydrate, 165 mg of (R)-N-(2-(p-methoxyphenyl)-1-methyl-ethyl)amine, 7 ml of dimethylsulfoxide, 7 ml of methanol and 38 mg of sodium borohydride are treated in the same manner as descri~ed in Example 2-(2) except that the reduction 15 reaction is conducted at 0 to 10C. Then, the reaction mixture is extracted with ethyl acetate. The extract is washed with water, dried and then concentrated under reduced p~essure to remove solvent. 10 ml of ethyl acetate and 10 ml of an aqueous 10 % potassium carbonate solution are added 20 to the residue, and 0.5 ml of acetyl chloride are added to the mixture with stirring under ice-cooling. The mixture is stirred at the same temperature for 30 minutes. The ethyl acetate layer is collected and washed with water and a saturated sodium chloride solution, successively. The 25 ethyl acetate solution is dried and concentrated under reduced pressure to remove solvent. The residue is chromato-. ~
, .

7~

graphed on the column of silica gel (solvent, methanol :
chloroform = 1 : 19), whereby the following two compounds are obtained, respectively.
8-benzyloxy-5-{(lR)-1-hydroxy-2-[N-((lR)-2-(p-methoxy-5 phenyl)-1-methylethyl)-N-acetylamino3ethyl}carbostyril Yield: 50 mg (10 ~), colorless caramel Mass ~/e): 482 (M -H2O) 8-benzyloxy-5-~(lS)-1-hydroxy-2-~N ((lR)-2-(p-methoxy-phenyl)-1-methylethyl)-N-acetylaminolethyl}carbostyril Yield: 410 mg (82 %), colorless carmel Mass (m/e): 482 (M -~2) (2) 8-benzyloxy-5-~(lR)-1-hydroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-methylethyl~-N-acetylamino3ethyl}carbostyril is treated in the same manner as described in Example 3 -(2-a) and (3-a), whereby 8-hydroxy-5-~(lR)-1-hydroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-mthylethyl)amino~ethyl~carbostyril hydrochloride is obtained.
Example 6 8-benzyloxy-5-~(lR)-1-hydroxy-2-~N-((lR)-2-(p-methoxy-20 phenyl)-1-methylethyl)-N-(p-nitrobenzoyl)amino~ethyl3carbostyril is obtained in the same manner as described in Example 5 -(1). A mixture of 3.7 g of 8-benzyloxy-5-i(lR)-l-hydroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)-N-(p-nitrobenzoyl)-amino~ ethyl~carbostyril, 100 ml of 96 ~ potassium hydroxide-25 ethanol and 10 ml of water is refluxed for one hour understirring. The mixture is concentrated under reduced pressure /

~2~

to remove solvent. The residue is extracted with chloroform, and the extract is washed with water, 10 ~ hydrochloric acid and a saturated sodium chloride solution, successively.
The chloroform solution is dried and concentrated under reduced pressure to remove solvent. The residue is recrystal-lized from an aqueous 10 % isopropanol solution. 1.85 g of 8-benzyloxy-5-~(lR)-1-hydroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)amino~ethyl~carbostyril hydrochloride are obtained as colorless prisms. Yield: 65 ~
The physico-chemical properties of this product are identical with those of the product obtained in Example
4-(2-a).
(3) 8-bezyloxy-S- t ( lR~-1-hydroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)amino3ethyl~carbostyriI hydrochloride 15 is treated in the same manner as described in Example 4 -(3-a), whereby 8-hydroxy-5-~(lR)-1-hydroxy-2-~N-~(lR)-2-(p-methoxyphenyl)-1-methylethyl)amino3ethyl~carbostyril hydrochloride is obtained.
Example 7 (1) 10 g of 8-benzyloxy-S-(dihydroxyacetyl)carbostyril 1/3 hydrate, S g of (R)-N-(2-(p-methoxyphenyl)-1-methylethyl)amine, 100 ml of dimethylsulfoxide, 100 ml of methanol and lulS g of sodium borohydride are treated in the same manner as described in Example 2 - (2). Then, the reaction mixture 25 is extracted with ethyl acetate. The extract is concentrated under reduced pressure to remove solvent. 250 ml of ethyl ~ 5'~7~

acetate and a slution of 8.36 g of potassium carbonate in 70 ml of water are added to the residue, and 3.76 g of chloroacetyl chloride are added aropwise thereto at 5 to 7C under stirring.
The ethyl acetate layer is collected and washed with water and a saturated sodium chloride solution, successively.
The ethyl acetate solution is dried and concentrated under reduced pressure to remove solvent. The residue is dissolved in 80 ml of hot methanol, and the solution is allowed to stand at room temperature. Crystalline precipitates are collected by filtration. 10.2 g of 8-benzyloxy-5-~lS)-1-hyroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-methylethyl~-N-chloro-acetylamino~ethyl}carbostyril hemihydrate are obtained as colorless needles. Yield: 61.9 %
M.p. 109 - 114C
Mass ~m/e): 516 (M -H2O) ~D -106.83 (c = 1.02, chloroform) (2) 7.12 g of 8~benzyloxy-5-~(lS)-l-hydroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)-N-chloroacetylamino~-ethyl}carbostyril hemihydrate are dissolved in a mixture of 70 ml of chloroform and 70 ml of methanol, and the solution is concentrated under reduced pressure to remove solvent.
The residue is dissolved in 70 ml of methylene chloride, and 2.38 g of thionyl chloride are added thereto at 5 to 7C.
The mixture is stirred at the same temperature for one hour.
Then, the mixture is concentrated under reduced pressure to remove solvent. The residue is dissolved in 70 ml of ~25~7~

dioxane, and 15 ml of water are added thereto at room temperature.
The mixture is stirred at the same temperature for one hour.
A solution of 9.3 g o 96 ~ potassium hydroxide in a mixture of 50 ml of water and 50 ml of methanol is added to the
5 mixture, and the mixture is stirred for 20 minutes. The mixture is concentrated under reduced pressure to remove solvent. The residue is extracted with ethyl acetate, and the extract is washed with water and a saturated sodium chloride solution, successively. The ethyl acetate solution lO is dried and concentrated under reduced pressure to remove solvent. The residue is recrystallized from a mixture of ethyl acetate and benzene. 4.13 g of 8-benzyloxy-5-{~lR)-1-hydroxy-2-~N-(tlR)-2-(p-methoxyphenyl)-1-methylethyl)amino~-ethyl}carbostyril are obtained as colorless needles.
15 Yield: 67.7 %
The physico-chemical properties of this product are identical with those of the product obtained in Example 4 - ~2-a).
(3) 8-benzyloxy-5-~(lR)-1-hydroxy-2-~N-((lR)-2-(p-20 methoxyphenyl)-1-methylethyl)amino3ethyl}carbostyril is treated in the same manner as described in Example 4 -(3-a), whereby 8-hydroxy-S-~(lR)-1-hydroxy-2-~N-((lR)-2-(p-methoxyphenyl)-1-methylethyl)amino]ethyl~carbostyril is obtained.

:

125~

Example 8 (1) 2 g of 8-benzyloxy-5-{1-hydroxy-2- [N-(2-(p-methoxyphenyl)-l-methylethyl)-N-acetylamino~ ethyl}carbostyril (B-isomer) are dissolved in 25 ml of methylene chloride, and 5 960 mg of thionyl chloride are added thereto at 5 to 10C.
The mixture is stirred at 10 to 15C for one hour. l~en, the mixtllre is concentrated under reduced pressure to remove excess thionyl chloride and methylene chloride. The residue is dissolved in 80 ml of water, and the solution is allowed 10 to stand at room temperature for 4 hours. The solution is concentrated under reduced pressure to remove water. The residue is crystallized with a mixture of water and tetrahydro-furan~ and the resultant crystals are recrystallized from a mixture of methanol, chloro~orm and ether. 1.6 g of 8-15 benzyloxy-5~ acet~xy-2- ~N-(2-(p-methoxyphenyl)-1-methylethyl)-amino~ ethyl} carbostyril (C(-isomer) hydrochioride-methanol are obtained as colorless prisms. Yielcl: 70.3 96 M.p. 175 - 178C (decomp.) ~lass (m/e): 501 (M + 1) , 500 (M ), 499 (M - 1) 440 (M, -cH3cooH) IR )~ mU~l (Cm ): 3350, 2400 - 2150, 1740, 1673 Free base:
NMR(CDCl3)~: 1.08 (d, J = 6.5Hz, 3H), 1.94 (s, 3H), 2.4 - 3.3 (m, 5H), 3.74 Is, 3H), 5.14 (s, 2H), 6.14 (q, J = 5.8Hz, lH),
6.6 - 7.1 ~m, 7H), 7.26(s, 5H~, 8.06 (d, J = 10Hz, lH), ~25~

l21 0.5 g of 8-benzyloxy-5-{1-acetoxy-2-~N-(2-tp-methoxyphenyl~-l-methylethyl)amino~ethyl~carbostyril (~-isomer) hydrochloride.methanol is dissolved in a mixture of lO ml of methanol and 2 ml of water, and 180 mg of triethylamine are 5 added thereto. The mixture is refluxed for 5 hours under stirring. The mixture is concentrated under reduced pressure to remove solvent. The residue is extracted with chloro~orm, and t~e extract is washed with 5 ~ hydrochloric acid. The chloroform solution is dried and concen~rated under reduced 10 pressure to remove solvent. The residue is recrystallized from a mixture of isopropanol and ether. 365 mg o~ 8-benzyloxy-5-~1-hydroxy-2-~N-(2-(p-methoxyphenyl)-1--methylethyl)amino~ethyl} -carbostyril (~-isomer) hydrochloride are obtained. Yield:
86.1 %
The physico-chemical properties of this product are identical with those of the product obtained in Example 3 -(2-a).
(3) 8-benzyloxy-5-{1-hydroxy-2-[N-(2-(p-methoxy-phenyl)-L-methylethyl)amino~ethyl}carbostyril(~-isomer~
20 hydochloride is treated in the same manner as described in Example 3 - (3-a), whereby 8-hydroxy-5-~L-hydroxy-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)amino~ethyl}carbotyril (~-isomer) hydrochloride is obtained.
_xample 9 (1) 100 mg of 8-benzyloxy-5-{1-hydroxy-2-~N-2-(p-methoxyphenyl)-l-methylethyl)-N-acetylamino)ethyl~carbostyril 125~7~

(B-isomer) are dissolved in 2 ml of methylene chloride, and 35.7 mg of thionyl chloride are added thereto under ice-cooling.
The mixture is stirred for 15 minutes. After the reaction, the mixture is concentrated under reduced pres sure. 4 ml 5 of dioxane are added to the residue. The mixture is ice-cool~d and 75 mg of potassium acetate are added thereto. The mixture is stirred at room temperature for 15 minutes. 40 mg of sodium hydroxide are added to the mixture, and the mixture is stirred at room temperature for O.S hour. After 10 the reaction, the mixture is extracted with ethyl acetate.
5 ml of an aqueous 5 ~ sodium hydroxide solution are added to the organic layer. The mixture is stirred under cooling and treated with 45 mg of acetyl chloride. After the reaction, the organic layer is collected, washed with water, 15 dried and then evaporated under reduced pressure to remove ethyl acetate. The residue is recrystallized from ethyl acetate. 80 mg o~ 8-benzyloxy-5-{1-hydroxy-2-tN-(2-(p-methoxy-phenyl) 1-methylethyl)-N-acetylamino~ethyl~carbostyril (~-isomer) are obtained as colorless needleds. Yield: 80 M.p. 177 ~ 180C
IR-spectrum and Rf-value of the product are identical with those of the product obtained in Example 3 - (1).
(2) 8-Benzyloxy-5-~1-hydroxy-2-~N-(2-(p-methoxyphenyl)~
1-methylethyl)-N-acetylamino3ethyl~carbostyril (~-isomer) is 25 converted to the corresponding B-isomer in the sa~e manner as described above.

~Z5~17l~

Example 10 (l) 10.84 g o~ 8-benzyloxy-S-(dihydroxyacetyl)-carbostyril 1/3 hydrate and 5.66 g o~ N-(2-(p-methoxyphenyl)-l-methylethy)amine are dissolved in lO0 ml of dimethylsulfoxide, 5 and the solution is stirred at room ~emperature for one hour. The mixture is extracted with chloroform, and the extract is washed with water and a saturated sodium chloride solution, successLvely. m e chloro~orm solution is dried and concentrated under reduced pressure to remove solvent.
10 The residue is crystallized with a mixture o~ ethyl acetate and n-hexane, and crystalline precipitates are collected by filtration. 13 g of 8-benzyloxy-5-~1-oxo-2-~N-(2-(p-methoxy-phenyl~-l-methylethyl)imino~ethyl}carbostyril are obtained as yellow solid. Yield: 87.6 M.p. 151 - 152C
Mass (m/e): 454 ~M ) IR ~ maUxol ~cm ): 1660, 1650 NMR~CDC133 ~: 1.32 (d, J = 7Hz, 3H), 2.8 - 2.9 ~m, 2H), 3.77 ~s, 3H0, 5.24 ~s, 3H), 6.70 and 8.58 ~lH each, d, J = lOHz), 6.79 and 7.04 ~2H each, d, J a 9Hz), 6.91 and 7.36 (lH each, d, J = 9Hz), 7.40 ~s, SH), 7.78 ~s, lH) (2) 8-benzyloxy-5-{1-oxo-2-~N-~2-(p-methoxyphenyl)-25 1-methylethylJimino3ethyl}carbostyril is treated in the same manner as described in Example 2 - (2) and (3), whereby , ., ~253~?7~ .

8-hydro~r5-~l-hydroxy-2-[N-(2-(p-methoxypheny~ -methylethyl) amino ethyl carbostyril is obtained. (a mixture of ~- and ~-isomers) Example 11 (lj One g of 8-benzyloxy-5-(dihydroxyaCetYl)carbostyri 1/3 hydrate and 520 mg of (R)-~-(2-(p-methoxyphenyl)-1-methyl-ethyl)amine are dissolved in 10 ml of dimethylsuloxide, and the solution is stirred at room temperature ~or one hourO
After the reaction is completed, the mixture is treated in 10 the same manner as described in Example 10 - (1). 1.06 g of 8-benzyloxy-5-{1-oxo-2-~N-((lR)-2-(p-methoxyphenyl)-1-methyl-ethyl)imino~ethyl~carbostyril are obtained as pale yellow scalesO Yield: 75 ~
M.p. 114 - 116C
~d]20 _97,50 (c = 1.06, methanol) IR~maUx 1 (cm 1): 1670, 1625 The Mass and NMR data of this product are identical with those of the product obtained in Example 10 -(1).
(2) 8-benzyloxy-S-{1-oxo-2-~N-((lR)-2-(p-methoxy-20 phenyl)-1-methylethyl)imino~ethyl~carbostyril is treated in the same manner as described in ~xample 2 - (2) and Example 5, whereby 8-hydroxy-S-{(lR)-1-hydroxy-2-[N-(~lR)-2-(p-methoxy-phenyl)-1-methylethyl)amino3ethyl}carbostyril hydrochloride is obtained.

~L 2r~;~?,rs~

Example 12 (1~ A solution o~ 1.65 g of (R)-N-(2-(p-methoxyphenyl) methylethyl)amine in 5 ml of dimethylsulfoxide is added to a solution of 3.3 g of 8-benzyloxy-5-(dihydroxyacetyl)carbostyril 1/3 hydrat~ in 45 ml of dimethylsulfoxide, and the mixture is stirred at room temperature for 30 minutesO 60 ml of methanol are added to the mixture under ice-cooling, and 0.39 g of sodium borohydride is added thereto at 5 to 10C.
The mixture is stirred at the same temperature for 15 minutes. The mixture is concentrated under reduced pressure to remove solvent. The residue is extracted with ethyl acetate, and the extract is washed with water and a saturated sodium chloride solution, successi~ely. The ethyl acetate solution is dried and concentrated under reduced pressure to remove solvent. The residue is converted to its hydrochloride, and the hydrochloride is crystallized with a mixture o~
isopropanol and and ethyl acetate. The resultant crystals are recrystallized 3 times from ethanol. 2.28 g of 8-benzyloxy-5-~(lS)-1-hydroxy-2- CN- ~ ( lR)-2-(p-mehoxyphenyl)-1-methylethyl~-amino~ethyl~carbostyril hydrochloride 1/3 ethanol hemihydrateare obtained as colorless needles. Yield: 46 %
M.p. 164.5 - 167C
C~DO + 9 60 (c - 1.0, methanol) Mass (m/e): 440 (M -H2O)) IR ~ nujol Icm~1): 3405, 3350, 3200, 2740 - 2450, 1650, 1605 .

'' "'' ~` :-5~ 3 MMR(d6-DMSO) :1.15 (d, J = 8Hz, 3H), 2.4 - 2.8 (m, 2H, 2. 82 - 3.9 (m, 4H), 3.72 (s, 3H), 4~36 (broad s, lH~, 5.33 (s, 2H), 6.58 (d, J
= lOHz, 1~), 6.86 (d, J = 9Hz, 2H),
7.14 td, J = 9Hz, 2~), 8.36 ~d, J =
lOHz, 1~), 6.8 - 7.7 (m, 7H) (2, 8-benzyloxy-5-{(lS)-1-hydroxy-2-~N-~(lR)-2-(p~
methoxyphenyl)-l-methylethyl)amino]ethyl~carbos~yril hydrochloride is treated in the same manner as described in Example 4 -(3-a), whereby 8-hydroxy-5-~(lS~-1-hydroxy-2-~N-((lR)-2-(p-methoxy-phenyl)-1-methylethyl~amino~ethyl¦carbostyril is obtained.
Example 13 (1) A solution of 7.8 g of bromine in 30 ml of methylene chloride is added dropwise to a refluxing solution 15 of 13 g of 5-acetyl-8-benzyloxycarbostyril and 7.56 g of boron trifluoride etherate in 170 ml of methylene chloride,and the mixture is refluxed for 30 minutes under heating. The mixture is concentrated under reduced pressure to remove solvent.
The residue is made alkaline with an aqueous 10 % potassium 20 carbonate solu~ion,.and the resultant precipitates are collected by filtration. The crystals are recrystallized from a mixture of chloroform and methanol. 12.51 g of 5-bromoacetyl-8-benzyloxycarbostyril are obtained as pale yellow needles.
~ield: 75.7 ~

~LZ~ 3 ~7L~

The physico-chemical properties of this product are identical with those of the product obtained in Example 1 -(1) .
(2) A mixture of 3.72 g of 5-bromoacetyl-8-benzyl-S oxycarbostyril, 3~3 g of N-(2-(p-methoxyphenyl)-1-methylethyl)-amine, 2.6 g of sodium bicarbonate, 10 ml of methylPne chloride and 2 ml of dimethylformamide is refluxed for 30 minutes under stirring. The mixture is concentrated under reduced pressure to remove solvent. The residue is extracted with chloroform, and the extract is washed with 10 ~ hydrochloric acid, dried and then concentrat~d under reduced pressure to remove solvent. The residue is rcrystallized form a mixture of ethanol and isopropanol. 3.53 g o~ 8-benzyloxy-5~ oxo-2-~N-(2-(p-methoxypheyl)-1-methylethyl)amino3ethyl~carbostyril 15 hydrochloride are obtained as colorless needles. Yield:
71.6 %
M~p. 201.5 - 208C (decomp.) Mass ~m~e): 456 (M ), 335, 121 IR ~ axl (cm ): 3380, 1690, 1660 (3) 8-benzyloxy-S-~1-oxo-2-~N-(2-(p-methoxyphenyl)-1-methylethyl)amino3ethyl~carbostyril hydrochloride is treated in the same manner as described in Example 1 - (2) and ~3), whereby 8-hydroxy-5-{l-hydroxy-2-~N-(2-(p-methoxyphenyl)-l-methylethy~amino~ethyl~carbostyril dihydrochloride is obtained.
(a mixture of ~- and B-isomers) lL2~9! ~74~

- ~6 -(Preparation of Starting Compounds) Preparation 1 (lJ 27 g of 5-acetyl-8-hydroxyquinoline hydrochloride are dissolved in 540 ml of anhydrous dimethylformamide and 50 g of powdered potassium carbonate are added thereto.
18.4 g of ~enzyl chloride are added to the mixture at 50C
under an argon atmosphere, and the mixture is stirred at the same temperature fox 4.5 houxs and then further stirred at room temperature for 1.5 hours. After the reaction, water is added to the mixture, and the aqueous mixtùre is extracted with ethyl acetate. The extract is washed with water, a saturated sodium chloride solution, dried and then evaporated under reduced pressure to remove ethyl acetate. The residue is recrystallized from ethanol. 19.1 g of 5-acetyl-8-benzyl-oxyquinoline are obtained as brownish prisms. 6.35 g ofsaid product are further recovered from the mother liquor.
Total yield: 25.S g (76.1 %) M.p. 131 - 133C
t2) 5 g of 5-acetyl-8-benzyloxyquinoline are dissolved in 50 ml of chloroform. The solution is ice-cooled and 3.12 g of 80 % m-chloroperbenzoic acid are added thereto under stirring. The mixture is stirred at room temperature for 24 hours and at 50C for 7.5 hours. The mixture is then stirred at room temperature for 64 hours. 2 g of 80 %
m-chloroperbenzoic acid are further added to the mixture during the reaction. After the reaction, chloroform is 31 2~r~7,~
- ~7 -added to the mixture. The mixture is washed with water, a 4 ~ sodium bicarbonate solution and a saturated sodium chloride solution, dried and then evaporated under reduced pressure to remove chloroform. 5-Acetyl-8-benzyloxyquinoline-N-oxide is obtained as yellow solid.
M.p. 136.5 - 137.5C (recrystallized from acetone) The yellow product obtained above is dissolved in 60 ml of acetic anhydride, and the solution is stirred at 100C
for 8.5 hours. After the reaction, the mixture is evaporated under reduced pressure and the residue is recrystallized from methanol. l.9S g of 5-acetyl-8-benzyloxycarbostyril are obtained as pale brownish prisms. 1.06 g of said product is further re¢overed from the mother liquor. Total yield: 3.01 g (56.8 %) M.p. 174 - 176C
PreParation 2 15.23 g of S-acetyl-8-hydroxycarbostyril and 15.7 g of benzyl chloride are added tO a mixture of 200 ml of acetone and 90 ml of water, and 10.35 g of potassium carbonate are added thereto. The mixture is refluxed for 12 hours under stirring. Then, the mixture is evaporated under reduced pressure to remove acetone, and the residue is extracted with chloroform. The extract is washed with water, dried and evaporated under reduced pressure to remove chloroform. The residue is recrystallized from a mixture of ethyl acetate and n-hexane. 10.14 g of 5-acetyl 8-benzyl-oxycarbostyril are obtained as prisms. 1.58 g of said ~ZS9~374 product are further recovered from the mother liquor.
Total yield: 11.72 g (53.3 ~) Preparation 3 (1) 19.3 g of ~-methyltX-nitro-p-methoxystyrene are dissolved in a mixture of 180 ml of methanol and 60 ml of tetrahydrofuran, and 11.4 g of sodium borohydride are added thereto under ice-cooling. The mixture is stirred at room temperature overnight. 3 g of 10 ~ palladium-charcoal and 30 ml of methanol, are added to the mixture, and the mix~ure is shaken at rcom temperature at an atmospheric pressure under a hydrogen atmosphere for 9 hours. Insoluble materials are filtered off, and the filtrate is concentrated under reduced pressure to remove solvent. The residue is extracted with chloroform, and the extract is dried and concentrated under reduced pressure to remove solvent. 15.5 g of N-(2-(p-methoxyphenyl)-1-methylethyl)amine are obtained as colorless oil. Yield: 94.4 % B.p. 110 - 115C/5 mm~g (2) 81.7 g of N-(2-(p-methoxyphenyl)-1-methylethyl)-amine and 150 g of (S)-1-(2-naphthylsulfonyl)pyrrolidine-2-carboxylic acid are dissolved in 1000 ml of methanol and thesolution is concentrated under reduced pressure to remove methanol. The residue is recystallized twice ~rom a mixture of ethyl acetate and isopropanol (1 : 1), ow e from isopropanol, twice from a mixture of isopropanol and ethanol (1 : 1) and then from a mixture of isopropanol and ethanol (1 : 2).
57.56 g of a salt of (R)-N-(2-(p-methoxyphenyl)-1-methylethyl)-~L,25~1 amine with [s)-1-(2-naphthylsulfonyl)Pyrrolidine-2-carboxyilic acid are obtained as colorless needles. M.p. 163.5 - 167C
The above-obfained salt ~57.56 g) is converted to its free base by using an aqueous potassium carbonate, and the free ~ase is distilled under reduced pressure. 14.22 g o~
tR)-N-(2-(p-methoxyphenyl)-1-methylethyl)amine are obtained as colorless oil. Yield: 35 % B.p. 90-95C/2 mmHg Hydrochloride:
M.p. 252 - 254C (decomp.) [~ D -23.2 (c = 2.0, water) :..,....,..,. .:-

Claims (6)

Claims:
1. A compound of the formula (I) (I) wherein YO is a protected hydroxy group.
2. A compound as claimed in claim 1 wherein YO is a substituted or unsubstituted phenyl-lower alkyloxy group.
3. A compound as claimed in claim 1 wherein YO is a benzyloxy group.
4. A process for preparing a compound of the formula:

(I) wherein YO is a protected hydroxy group, which comprises the step(s) of:
reducing a compound of the formula:

(II) (III) wherein YO- is a hydroxy group or a protected hydroxy group.
5. A process as claimed in claim 4 wherein YO is a substituted or unsubstituted phenyl-lower alkyloxy group.
6. A process as claimed in claim 4 wherein YO is a benzyloxy group.
CA000562864A 1983-12-24 1988-03-29 Carbostyril derivative and process for preparing same Expired CA1259074A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000562864A CA1259074A (en) 1983-12-24 1988-03-29 Carbostyril derivative and process for preparing same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB838334494A GB8334494D0 (en) 1983-12-24 1983-12-24 Carbostyril derivatives
GB8334494 1983-12-24
CA000470917A CA1258859A (en) 1983-12-24 1984-12-21 Carbostyril derivative and process for preparing same
CA000562864A CA1259074A (en) 1983-12-24 1988-03-29 Carbostyril derivative and process for preparing same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000470917A Division CA1258859A (en) 1983-12-24 1984-12-21 Carbostyril derivative and process for preparing same

Publications (1)

Publication Number Publication Date
CA1259074A true CA1259074A (en) 1989-09-05

Family

ID=25670554

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000562864A Expired CA1259074A (en) 1983-12-24 1988-03-29 Carbostyril derivative and process for preparing same

Country Status (1)

Country Link
CA (1) CA1259074A (en)

Similar Documents

Publication Publication Date Title
US4579854A (en) Bronchodilating 8-hydroxy-5-{(1R)-1-hydroxy-2-[N-((1R)-2-(p-methoxyphenyl)-1-methylethyl)-amino]ethyl} carbostyril
CA1101430A (en) Derivatives of 4-amino 5-alkylsulphonyl ortho- anisamides, methods of preparing them
KR920003819B1 (en) Process for the preparation of (S) -alpha-ethyl-2-oxo-1-pyrrolidineacetamide
KR850000302B1 (en) Process for preparing octahydro-1h-indole-2-carboxylic acid derivatives
US4172896A (en) Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
CA2115020A1 (en) Morpholine derivatives and their use
EP0252823B1 (en) 1H,3H-pyrrolo[1,2-c]thiazole derivatives, their preparation and pharmaceutical compositions containing them
FR2472574A1 (en) CEPHALOSPORINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
RU2120435C1 (en) 2-amino-1,2,3,4-tetrahydronaphtalene derivatives or pharmaceutically acceptable salts thereof, and composition having cardiovascular activity
WO1999007696A1 (en) Quinolizine carboxylic acid derivatives
US5171752A (en) Benzhydryl derivatives having calmodulin inhibitor properties
CA1259074A (en) Carbostyril derivative and process for preparing same
EP0229370B1 (en) Guanidinobenzoic ester derivative, a process for preparing same and pharmaceutical compositions containing same
EP0093805B1 (en) Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
US4780477A (en) Isatin compositions having anti-ulcer activities
JPH09501954A (en) Imidazo [5,1-c] [1,4] benzoxazin-1-one imidazolylalkyl derivatives and processes for their preparation
NO309475B1 (en) Thiazolidinone compounds and therapeutic or prophylactic agent against angina pectoris comprising the compounds as active ingredient
AU600149B2 (en) A thiophene derivative and process for preparing the same
US6069257A (en) Process for the production of tetrazolylbenzopyrans
US4287211A (en) Derivatives of phenylethylamines, processes for their preparation and related pharmaceutical compositions
US4380644A (en) 2-Oxoimidazolidine derivatives
US4436740A (en) 3-Cycloalkylamino-2-OR-propoxycyanopyridines
US4859680A (en) Pyrimidine derivatives as antiviral compounds
US4082801A (en) 4-Aminomethyldibenzobicyclo[5.1.0]octanes
KR940004059B1 (en) Bicyclolactam derivatives

Legal Events

Date Code Title Description
MKEX Expiry